Invention Grant
- Patent Title: Primer set for detection of Zaire ebola virus, assay kit, and amplification method
-
Application No.: US15626938Application Date: 2017-06-19
-
Publication No.: US10563249B2Publication Date: 2020-02-18
- Inventor: Jiro Yasuda , Yohei Kurosaki
- Applicant: Nagasaki University , Toshiba Medical Systems Corporation
- Applicant Address: JP Nagasaki-shi JP Otawara-shi
- Assignee: Nagasaki University,Canon Madical Systems Corporation
- Current Assignee: Nagasaki University,Canon Madical Systems Corporation
- Current Assignee Address: JP Nagasaki-shi JP Otawara-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2014-258074 20141219; JP2015-123538 20150619
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/06 ; C12N15/70 ; C12Q1/6853 ; C12Q1/686 ; C12Q1/6851
Abstract:
According to one embodiment, there is provided a nucleic acid primer set that amplifies a ZEBOV gene. An F1 sequence includes at least 13 consecutive bases included in SEQ ID NO: 31 or 64. An F2 sequence includes at least 13 bases included in SEQ ID NO: 62 or 63. An F3 sequence includes at least 13 bases included in SEQ ID NO: 29, 36, 38, 55, 56, 57, 58, 59, 60, 61 or 61. A B1c sequence includes at least 13 bases included in SEQ ID NO: 68, 69, 70, 71, 72, 73, 74 or 75. A B2c sequence includes at least 13 bases included in SEQ ID NO: 65 or 66. A B3c sequence includes at least 13 bases included in SEQ ID NO: 34, 67, 82 or 83.
Public/Granted literature
- US20170369940A1 PRIMER SET FOR DETECTION OF ZAIRE EBOLA VIRUS, ASSAY KIT, AND AMPLIFICATION METHOD Public/Granted day:2017-12-28
Information query
